AEDs pharmacology Flashcards
Acetazolamide
Carbonic anhydrase inhibitor
Carbamazepine MOA
Prevents repetitive firing of voltage-gated Na-channels, slows recovery of Na-channels: NaF (fast sodium current)
Also works on Ca L-type channels
Auto-inducer
Clobazam
GABA-A receptor agonist
Benzodiazepine derivative (1,5 benzodiazepine with lower abuse potential than 1,4 benzodiazepines like diazepam and lorazepam)
Clonazepam
GABA-A receptor agonist
*Benzodiazepines increase channel opening frequency whereas barbiturates increase channel opening duration
Eslicarbazepine
Similar to CBZ, i.e., inhibition of voltage-gated Na channels through slower channel recovery: NaF (fast sodium current)
Has longer half-life compared to CBZ
Ethosuximide
Reduces low-threshold T-type Ca currents in thalamic neurons - blocks T-type Ca-channels. *Maybe some action via NaP: persistent sodium current
Ezogabine
Potassium channel opener, particularly KCNQ2-5 channels
Felbamate
Inhibition of NMDA receptors
Potentiation of GABA-A receptors
Can cause rare but fatal aplastic anemia or hepatotoxicity (I FELL down because Felbatol made me so sick)
Gabapentin MOA
Bind pre-synaptic voltage-gated Ca channels (HVA, alpha-2-delta-1 subunit), resulting in inhibition of excitatory neurotransmitters
Also enhances GABA turnover
Structurally similar to GABA but does NOT bind GABA receptor
Excreted unchanged in urine
Lacosamide MOA
Enhances slow inactivation of voltage gated Na channels (NaP: persistent sodium current), resulting in stabilization of neuronal membranes
Binds to collapsing response mediator protein 2 (CRMP-2), which is associated with neuronal outgrowth
Excreted without metabolism
Lamotrigine MOA
Inhibition of voltage-gated Na channels: slows their recovery - NaF (fast sodium current)
Inhibits high-voltage calcium currents (mediated by multiple channel types) - HVA calcium channel
Metabolism: hepatic glucuronidation
Depakote: decreases hepatic glucuronidation and increases lamotrigine levels
Pregnancy / hormonal interactions: 1.) Metabolism increased by estrogen-based OCPs 2.) Metabolism increased during pregnancy (monitor levels during & after, related to estrogen levels) and taper after childbirth
Levetiracetam MOA
Acts on the synaptic vesicle protein 2A (SV2A).
Inhibits N-type Ca currents: HVA
Also acts on GABA: Rev DMCM
Renal excretion without involvement of CP450 system
*Brivaracetam: inhibits SV2A protein with 30% greater affinity; not as many mood side effects as Keppra
Oxcarbazepine MOA
Metabolite MHD is a blocker of voltage-gated Na channel, slows their recovery: acts on NaF (fast sodium current)
Perampanel
Non-competitive antagonist of AMPA receptors on post-synpatic neurons
Can cause severe behavior changes including aggression, anger, homicidal ideation (Fycompa = Fight)
Phenytoin MOA
Blockage of voltage-gated Na channels: NaF (fast sodium current) and NaP (persistent sodium current)
Zero-order kinetics, unpredictable levels at high doses
Enzyme inducer
Pregabalin MOA
Bind pre-synaptic voltage-gated Ca channels (alpha-2-delta-1 subunit), resulting in inhibition of excitatory neurotransmitters
Also enhances GABA turnover
Excreted unchanged in urine